Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Focus-outbril op emmetropisatie bij Chinese kinderen

17 november 2026 bijgewerkt door: Children's Hospital of Fudan University

Effect van perifere focus-outbril op emmetropisatie bij Chinese kinderen van 6-8 jaar: 2 jaar gerandomiseerde klinische studie.

The purpose of this study is to characterize the effects of peripheral focous-out glasses on emmetropization in non-myopic Chinese Children Aged 6-8 Years.This is a prospective, parallel-controlled randomized trial.

Studie Overzicht

Gedetailleerde beschrijving

Myopia is one of the most common eye diseases that cause visual impairment and blindness, and the high rate of myopia in young people is a major public health issue. Based on the clinical studies of optical defocusing to regulate eye growth and refractive changes through visual signal feedback, we hypothesize that early wearing of peripheral defocus glasses in children can slow down the process of emmetropization and even prevent the onset of myopia by producing more myopic defocusing. The aim of this study is to investigate whether wearing peripheral defocus glasses can effectively delay emmetropization in non-myopic children aged 6-8 years , and to further explore its effect on preventing the onset of myopia.

The study adopts a 2-year,single-centre, randomized, parallel-controlled trial with a non-blinded design. Subjects who pass the screening period will have their baseline data collected and will be assigned to the experimental or control groups according to the randomization principle. The experimental group will be fitted with Direct Emmetropia with Focus-out Glasses (hereafter referred to as DEFOG) to guide the emmetropization process. The control group will be given no treatment and will be a blank control. Baseline data including visual acuity, cycloplegic objective refraction, axis length, accommodation amplitude, strabismus examination, pupil size, choroidal thickness and peripheral retinal refraction will be measured when enrolled in the group and follow-up data will be measured at month 6, 12, 18 and 24. The primary interest of this study will be studied by comparing the difference in cycloplegic objective refraction changes between month 24 and baseline in the two groups of subjects.

Studietype

Ingrijpend

Inschrijving (Werkelijk)

160

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, China, 201110
        • Children's Hospital of Fudan University

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

6 jaar tot 8 jaar (Kind)

Accepteert gezonde vrijwilligers

Ja

Geslachten die in aanmerking komen voor studie

Allemaal

Beschrijving

Inclusion Criteria:

  1. Age: ≥6 and ≤8 years at enrollment.
  2. At least one parent' s Spherical equivalent refraction≤-3.00D.
  3. Spherical equivalent refractions (SERs) under cycloplegia: +0.50 to +1.50 diopters (D)
  4. Astigmatism ≤1.00 D .
  5. Anisometropia ≤1.00 D.
  6. Best Corrected Visual Acuity (BCVA) : 1.0 or better
  7. Provision of consent written by subject's legal guardian
  8. Willing and able to participate in all required activities of the study

Exclusion Criteria:

  1. Any of the following abnormalities on the ocular surface, such as trachoma, pemphigoid, chemical injury, heat burn, radiation injury, etc.
  2. Eyelid abnormalities (e.g. entropion, ectropion, tumor, edema, blepharospasm, incomplete eyelid closure, severe trichiasis, severe ptosis) ,which affect eyelid function in either eye
  3. Eye diseases such as strabismus, amblyopia, anisometropia, fundus diseases, and accommodation abnormality,etc.
  4. Prior treatment of myopia control in either eye, including but not limited to drugs, orthokeratology, low-level red-light therapy, etc.
  5. Noncompliance with measurement at enrollment.

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Preventie
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Geen (open label)

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: DEFOG group

Subjescts will wear DEFOG glasses(peripheral focus-out glasses).

Subjects in the intervention group will wear peripheral focus-out glasses ≧8 hours a day and ≧5 days a week.

Geen tussenkomst: Control group

Subjects in the control group will just be observed.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Overall Changes of Cycloplegic Objective Refraction(spherical equivalent refraction, SER)(D)
Tijdsspanne: From baseline till the 24th month

Changes of cycloplegic objective refraction(i.e reflected by SER) from baseline till the 24th month (only the right-eye data included). Objective refraction data will be examined by AUTO REF/KERATOMETER. Ciliary muscle paralysis will be performed by using 1% cyclopentanone eye drops, 2 doses in each eye, 2 doses 5 minutes apart. The optometry will be performed after 20 minutes of complete ciliary muscle paralysis (disappearance of pupil response to light or pupil diameter at least greater than 6 mm). SER is calculated by adding the sum of the sphere power with half of the cylinder power. Baseline data will be measured at the time of enrollment. Follow-up data will be measured on the 24th month from baseline. The 24th month data will be subtracted from the baseline data to obtain changes.

From baseline till the 24th month

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Changes of Cycloplegic Objective Refraction(SER) (D)
Tijdsspanne: The 6th month, the 12th month and the 18th month from baseline

Changes of cycloplegic objective refraction (i.e reflected by SER) different follow-up time and the baseline time (only the right-eye data included). Objective refraction data will be examined by AUTO REF/KERATOMETER.

The 6th month, the 12th month and the 18th month from baseline
Myopia
Tijdsspanne: The 6th month, the 12th month, the 18th month and the 24th month from baseline

Cycloplegic SER≦-0.50D at any follow-up time. Objective refraction data will be examined by AUTO REF/KERATOMETER.

The 6th month, the 12th month, the 18th month and the 24th month from baseline
Changes of Axial Length(AL)(mm)
Tijdsspanne: The 6th month, the 12th month, the 18th month and the 24th month from baseline

Changes of Axial Length (AL) between different follow-up time and the baseline time (only the right-eye data included).AL will be examined by IOL Master.

The 6th month, the 12th month, the 18th month and the 24th month from baseline
Amplitude of Accommodation (AMP)(D)
Tijdsspanne: The 6th month, the 12th month, the 18th month and the 24th month from baseline

Amplitude of Accommodation (AMP) at any follow-up time (only the right-eye data included). AMP will be examined by lens test.

The 6th month, the 12th month, the 18th month and the 24th month from baseline
Uncorrected Visual Acuity
Tijdsspanne: The 6th month, the 12th month, the 18th month and the 24th month from baseline

The Logarithmic Visual Acuity at any follow-up time (only the right-eye data included).

The 6th month, the 12th month, the 18th month and the 24th month from baseline
Strabismus Examination(△)
Tijdsspanne: The 6th month, the 12th month, the 18th month and the 24th month from baseline

Strabismus examination at any follow-up time by SYNOPTOPHORE.

The 6th month, the 12th month, the 18th month and the 24th month from baseline
Changes of Choroidal Thickness (ChT) (um)
Tijdsspanne: The 6th month, the 12th month, the 18th month and the 24th month from baseline

Changes of Choroidal Thickness (ChT)between different follow-up time and the baseline time (only the right-eye data included). ChT will be examined by OPTICALCOHERENCETOMOGRAPHY.

The 6th month, the 12th month, the 18th month and the 24th month from baseline
Pupil size(mm)
Tijdsspanne: The 6th month, the 12th month, the 18th month and the 24th month from baseline

Pupil size at any follow-up time (only the right-eye data included).

The 6th month, the 12th month, the 18th month and the 24th month from baseline
Peripheral Retinal Refraction(D)
Tijdsspanne: The 6th month, the 12th month, the 18th month and the 24th month from baseline

Peripheral Retinal Refraction at any follow-up time (only the right-eye data included). Peripheral Retinal Refraction will be examined by AUTO FUNDUS CAMERA.

The 6th month, the 12th month, the 18th month and the 24th month from baseline
The percentage of participants with fast myopic shift
Tijdsspanne: From baseline till the 24th month

The percentage of participants with fast myopic shift over 2 years(only the right-eye data included). The fast myopic shift is defined as cycloplegic objective refraction (i.e reflected by SER) myopic shift of at least 1.00 D. Objective refraction data will be examined by AUTO REF/KERATOMETER.

From baseline till the 24th month
Corneal curvature(D) or radius of curvature(mm)
Tijdsspanne: The 6th month, the 12th month, the 18th month and the 24th month from baseline

Corneal curvature or radius of curvature(only the right-eye included). They can be interconverted. Data will be examined by AUTO REF/KERATOMETER.

The 6th month, the 12th month, the 18th month and the 24th month from baseline
Astigmatism (D)
Tijdsspanne: The 6th month, the 12th month, the 18th month and the 24th month from baseline

The adtigmatism at any follow-up time (only the right-eye data included).

The 6th month, the 12th month, the 18th month and the 24th month from baseline

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Publicaties en nuttige links

De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

23 maart 2023

Primaire voltooiing (Werkelijk)

2 april 2026

Studie voltooiing (Werkelijk)

2 april 2026

Studieregistratiedata

Eerst ingediend

10 januari 2023

Eerst ingediend dat voldeed aan de QC-criteria

10 januari 2023

Eerst geplaatst (Werkelijk)

19 januari 2023

Updates van studierecords

Laatste update geplaatst (Werkelijk)

20 november 2026

Laatste update ingediend die voldeed aan QC-criteria

17 november 2026

Laatst geverifieerd

1 november 2026

Meer informatie

Termen gerelateerd aan deze studie

Aanvullende relevante MeSH-voorwaarden

Andere studie-ID-nummers

  • DEFOG

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

NEE

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren